SWOG Cancer Research Network runs publicly funded clinical trials that have saved 3 million+ years of life. Founded by the National Cancer Institute in 1956.
SWOG researchers give #ASCO26 oral presentations on results of 2 GI trials, a testicular cancer study, work on vit D & neuropathy, big-picture results from S1609 DART rare cancers trial, & an AI prediction model in breast cancer! @SWOG ASCO calendar is at swog.org/media/26051.
Blog post from SWOG chairs @DrDawnHershman & @PrimoLaraMD:
SWOG Establishes An APP & Nurse Scientist Cmte
Our new cmte recognizes the contributions of APPs & nurse scientists & will help empower more of them to contribute to their full scope of practice.
swog.org/news-events/news/20…
Front Line post by @SWOG chairs @DrDawnHershman & @PrimoLaraMD:
The Next Era of SWOG Success
We see trials that are more streamlined & decentralized, that integrate community & advocate voices, that ask questions only public-powered research will answer.
swog.org/news-events/news/20…
Our @SWOG Chairs' blog:
A Team Science Leadership Team
SWOG is all about interdisciplinary collaboration and team science. We think a leadership approach with dual principal investigators who bring complementary skillsets and expertise is a great fit.
swog.org/news-events/news/20…
Saying Thank You:
@SWOGChair Dr. Charles Blanke's last Front Line post as chair of @SWOG:
"I have been honored to serve as chair of this research group over the last 13 years, and I could not be prouder of what you have accomplished in that time."
swog.org/news-events/news/20…
Registration is open for SWOG's spring group meeting, April 30-May 2, in San Francisco!
Incoming Group Chairs Drs. Primo Lara, Jr., & Dawn Hershman invite SWOG members to bring questions, concerns, & ideas to an interactive Friday plenary.
Learn more at swog.org/news-events/swog-me…
Extensive stage small cell lung cancer can be hard to treat — but study S2409 (the PRISM trial) is looking for better, personalized options. To learn more, visit SWOG.org/S2409 or call 1-800-4-CANCER. #LCSM#SCLC
S2213 is an #ALamyloidosis#clinicaltrial to determine if Dara-VCD drug treatment or stem cell transplant is better for patients. The study may be an option if your treatment plan could safely include a stem cell transplant. SWOG.org/S2213. Or call 1-800-4- CANCER.
For all @SWOG early career researchers in #genitourinary cancers:
The Nicholas Vogelzang GU Scholars Program
Includes mentorship and travel support - apply by January 15
thehopefoundation.org/vogelz…
#ClinicalTrial S2409 (PRISM) asks if it’s possible to personalize treatment for extensive stage small cell lung cancer. It compares standard treatment alone to standard treatment plus a drug matched to the cancer subtype. Learn more: SWOG.org/S2409 or 1-800-4-CANCER.
Have you had treatment for muscle invasive #BladderCancer? Are you expecting surgery next?
If your scans show no cancer, you may be able to join #ClinicalTrial S2427 (also called BRIGHT).
Visit SWOG.org/S2427 to learn more. Or call 1-800-4-CANCER. #BladderPreservation
Just activated!
#NCTN S2433 trial is enrolling patients with locally advanced or metastatic #pancreatic ductal
adenocarcinoma without KRAS or BRAF V600E mutations. Randomized to physician’s choice
SOC w/wo panitumumab.
PI: Rachael A. Safyan, MD @fredhutchswog.org/clinical-trials/S24…
Bladder removal surgery can have a big impact on quality of life. Study S2427 (also called BRIGHT) is testing a possible #BladderSparing approach for people with muscle invasive #BladderCancer. To learn more, visit SWOG.org/S2427 or call 1-800-4-CANCER. #MIBC
If you have extensive stage small cell lung cancer (ES-SCLC) and you haven’t started initial treatment, ask your doctor about study S2409 (PRISM). It tests the cancer for certain features to match patients with treatments. SWOG.org/S2409. 1-800-4-CANCER. #LCSM#SCLC
Study S2213 asks if a drug combination known as Dara-VCD or stem cell transplant is better for treating AL #amyloidosis. It tests how well the treatments work, and how they affect quality of life. Learn more at SWOG.org/S2213. Or call 1-800-4-CANCER. #clinicaltrial
#ClinicalTrial S2409 PRISM randomizes patients with extensive stage small cell lung cancer to durvalumab with or without a drug that’s targeted to their specific #SCLC subtype.
Co-PI: Nan Sethakorn, MD, PhD @LoyolaHealthswog.org/clinical-trials/S24…
S2427 BRIGHT trial tests IO + RT as bladder-preserving tx for patients with MIBC who respond to NAT.
PROs track QoL and treatment-related symptomatic toxicities.
Systematic biopsies needed at post-NAT TURBT.
Co-PI: James B. Yu, MD, MHS @DartmouthCancerswog.org/clinical-trials/S24…
If you have extensive stage small cell lung cancer (ES-SCLC) and you haven’t finished initial treatment, ask your doctor about study S2409 (PRISM). It tests the cancer for certain features to match patients with treatments. SWOG.org/S2409. 1-800-4-CANCER. #LCSM#SCLC
Are you getting treatment for muscle invasive bladder cancer? Ask your doctor about S2427 (BRIGHT). It’s a #ClinicalTrial testing whether an immunotherapy drug plus radiation therapy can help patients keep their bladder. SWOG.org/S2427. 1-800-4-CANCER. #MIBC
Are you starting treatment for #ALAmyloidosis? Ask your doctor about #clinicaltrial S2213. It compares using a drug combination called Dara-VCD vs. stem cell transplant. Learn more at SWOG.org/S2213. Or call 1-800-4-CANCER. #raredisease
The S2409 PRISM trial biomarker-tests patients with extensive stage small cell #LungCancer during induction treatment and assigns them to 1 of 3 maintenance therapy cohorts based on #SCLC subtype and SLFN11 status. #LCSM
Co-PI: So Yeon Kim, MD @YaleCancerswog.org/clinical-trials/S24…
S2427 BRIGHT tests IO + RT as bladder-preserving treatment for patients with #MIBC who respond to NAT.
Focal, non-diffuse carcinoma in situ (CIS) is allowed.
Systematic biopsies needed at post-NAT TURBT.
Co-PI: Daniel A. Hamstra, MD, PhD @BCMCancerCenterswog.org/clinical-trials/S24…
S2427 (BRIGHT) is a study for people who were treated for muscle invasive #BladderCancer — and the cancer shrunk or can’t be found after treatment. The study asks if a drug plus radiation can help prevent bladder removal. Visit SWOG.org/S2427. Or call 1-800-4-CANCER.
S2409 (the PRISM trial) is a study for people with extensive stage small cell lung cancer (ES-SCLC). The goal is to match different #SCLC subtypes with the best treatment. Visit SWOG.org/S2409. Or call 1-800-4-CANCER. #LCSM
Our @SWOGChair blog:
SWOG at SABCS: A Record of Success
The San Antonio Breast Cancer Symposium has been a prime venue for publishing important SWOG research results in breast cancer treatment, symptom management, and prevention. #SABCS25swog.org/news-events/news/20…
#Clinicaltrial S2213 asks if a drug combination (called Dara-VCD) or stem cell transplant is better for people with AL #amyloidosis. The trial is for people who haven’t started treatment yet. Learn more at SWOG.org/S2213. Or call 1-800-4-CANCER.
S2409 PRISM is testing whether it’s feasible to identify each patient’s small cell #LungCancer subtype and use that information to select the best therapy for that patient. #SCLC
Co-PI: Alberto Chiappori, MD @MoffittNewsswog.org/clinical-trials/S24…
If patients w #MIBC have a clinically sig response to NAT, is cystectomy needed? S2427 BRIGHT trial tests whether pembro + RT can let patients keep their bladder. Systematic biopsies needed at post-NAT TURBT.
Co-PI: Abhishek Tripathi, MD @cityofhopeswog.org/clinical-trials/S24…
Our @SWOGChair's blog:
Thank You
Through a year that’s had more than its share of uncertainties, I’m thankful for you, SWOG’s members and supporters, for all you do to care for our patients and advance our research.
swog.org/news-events/news/20…
Study S2213 is for people with newly diagnosed #ALAmyloidosis. It compares a combination of immunotherapy and chemo drugs (called Dara-VCD) to stem cell transplant. Learn more at SWOG.org/S2213. Or call 1-800-4-CANCER. Ask about S2213. #raredisease#mmsm
S2427 BRIGHT trial: In patients with #MIBC, can immunoradiotherapy after response to neoadj therapy (cT0 or cT1) allow for bladder preservation?
Systematic biopsies needed at post-NAT TURBT pre-registration.
Co-PI: @siadaneshmand@uscnorrisswog.org/clinical-trials/S24…
Our @SWOGChair's blog:
SWOG Is All Over ASH 2025
#ASH25 will feature a sizeable group of posters and presentations reporting on (or responding to) @SWOG research. Here are some highlights.
swog.org/news-events/news/20…
Our @SWOGChair blog:
This Thanksgiving, It's All About Hope
Thanksgiving is still a couple of weeks out, but high on my list of what I’m thankful for is having the strong support of The Hope Foundation for Cancer Research. @SupportingSWOGswog.org/news-events/news/20…
Our @SWOGChair's blog:
Stories of SWOG Accrual Stars
We have many inspiring stories of members and sites going above and beyond to enroll robustly to our trials.
swog.org/news-events/news/20…